Dysfunctional efferocytosis impairs clearance of apoptotic cells in disease. A new study shows that glutamine catabolism supports efficient apoptotic cell efferocytosis via non-canonical glutamine transamination but not canonical GLUD1-dependent α-ketoglutarate production, in a process that may operate in human atherosclerosis.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Merlin, J. et al. Nat. Metab. https://doi.org/10.1038/s42255-021-00471-y (2021).
Morioka, S. et al. Nature 539, 714–718 (2019).
Zhang, S. et al. Cell Metab. 29, 443–456.e5 (2019).
Park, D. et al. Nature 477, 220–224 (2011).
Yurdagul, A. Jr et al. Cell Metab. 31, 518–533.e10 (2020).
Jha, A. K. et al. Immunity 42, 419–430 (2015).
Liu, P. S. et al. Nat. Immunol. 18, 985–994 (2017).
Viràg, L. et al. Redox Biol. 26, 2213–2317 (2019).
Werfel, T. & Cook, R. S. Semin. Immunopathol. 40, 545–554 (2018).
Oh, M. H. et al. J. Clin. Investig. 130, 3865–3884 (2020).
The authors declare no competing interests.
About this article
Cite this article
Jaccard, A., Li, X. & Ho, PC. Glutamine gluttony of efferocytes. Nat Metab 3, 1280–1281 (2021). https://doi.org/10.1038/s42255-021-00462-z